Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Feb-24 8:07 PM View:  | Lin Charles Y SR VP, RESEARCH & DEVELOPMENT | Kronos Bio, Inc. (KRON) | 21-Feb-24 | Sale | 12,036 | $1.05 | $12,684.70 | (5%) 246.64K to 234.6K | |
| 23-Feb-24 8:12 PM View: | Olek Elizabeth A SR VP, CLINICAL SCIENCE | Kronos Bio, Inc. (KRON) | 21-Feb-24 | Sale | 7,368 | $1.05 | $7,765.14 | (4%) 200.64K to 193.28K | |
| 23-Feb-24 8:04 PM View: | Frisbee Allison SR VP, CORP OPERATIONS & LEGAL | Kronos Bio, Inc. (KRON) | 21-Feb-24 | Sale | 12,105 | $1.05 | $12,757.50 | (6%) 216.62K to 204.51K | |
| 16-Feb-24 8:34 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 15-Feb-24 | Grant | 270,339 | -- | -- | 3% 7.97M to 8.24M | |
| 05-Jan-24 6:30 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 04-Jan-24 | Sale | 7,366 | $1.18 | $8,718.40 | (3%) 268.33K to 260.97K | |
| 05-Jan-24 6:26 PM View: | Kosacz Barbara COO & General Counsel | Kronos Bio, Inc. (KRON) | 04-Jan-24 | Sale | 10,676 | $1.18 | $12,636.10 | (1%) 939.64K to 928.97K | |
| 05-Jan-24 6:27 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 04-Jan-24 | Sale | 12,009 | $1.18 | $14,213.90 | (4%) 327.25K to 315.25K | |
| 13-Dec-23 4:09 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 12-Dec-23 | Sale | 17,367 | $1.30 | $22,663.90 | (5%) 344.62K to 327.25K | |
| 13-Dec-23 4:10 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 12-Dec-23 | Sale | 10,032 | $1.30 | $13,091.80 | (4%) 278.37K to 268.33K | |
| 17-Nov-23 5:41 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 17-Nov-23 | Purchase | 97,935 | $1.08 | $106,162.00 | 1% 7.87M to 7.97M | |
| 17-Nov-23 5:41 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 16-Nov-23 | Purchase | 262,433 | $1.00 | $261,514.00 | 3% 7.61M to 7.87M | |
| 17-Nov-23 5:41 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 15-Nov-23 | Private Purchase | 1,370,690 | $0.80 | $1,102,720.00 | 22% 6.24M to 7.61M | |
| 07-Jul-23 4:08 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 06-Jul-23 | Sale | 6,634 | $1.75 | $11,624.80 | (2%) 285.0K to 278.37K | |
| 07-Jul-23 4:07 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 06-Jul-23 | Sale | 10,818 | $1.75 | $18,956.40 | (3%) 355.44K to 344.62K | |
| 07-Jul-23 4:06 PM View: | Al-Wakeel Yasir B. Chief Financial Officer | Kronos Bio, Inc. (KRON) | 06-Jul-23 | Sale | 9,617 | $1.75 | $16,851.90 | (3%) 355.72K to 346.1K | |
| 26-Jun-23 4:15 PM View: | Ridloff Elena Director | Kronos Bio, Inc. (KRON) | 22-Jun-23 | Grant | 11,333 | -- | -- | 431% 2.63K to 13.96K | |
| 24-Feb-23 9:36 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 24-Feb-23 | Sale | 6,291 | $1.74 | $10,918.00 | (2%) 291.29K to 285.0K | |
| 24-Feb-23 9:35 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 24-Feb-23 | Sale | 10,153 | $1.74 | $17,620.50 | (3%) 365.59K to 355.44K | |
| 24-Feb-23 9:34 PM View: | Al-Wakeel Yasir B. Chief Financial Officer | Kronos Bio, Inc. (KRON) | 24-Feb-23 | Sale | 9,026 | $1.74 | $15,664.60 | (2%) 364.75K to 355.72K | |
| 17-Feb-23 4:16 PM View: | Al-Wakeel Yasir B. Chief Financial Officer | Kronos Bio, Inc. (KRON) | 15-Feb-23 | Grant | 138,911 | -- | -- | 62% 225.83K to 364.75K | |
| 17-Feb-23 4:21 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 15-Feb-23 | Grant | 119,882 | -- | -- | 70% 171.41K to 291.29K | |
| 17-Feb-23 10:00 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 15-Feb-23 | Grant | 137,008 | -- | -- | 60% 228.59K to 365.59K | |
| 17-Feb-23 4:19 PM View: | Kosacz Barbara COO & General Counsel | Kronos Bio, Inc. (KRON) | 15-Feb-23 | Grant | 138,911 | -- | -- | 17% 800.73K to 939.64K | |
| 14-Dec-22 4:35 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 12-Dec-22 | Sale | 18,657 | $1.81 | $33,679.60 | (8%) 238.13K to 219.48K | |
| 14-Dec-22 4:31 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 12-Dec-22 | Sale | 9,138 | $1.81 | $16,495.90 | (5%) 172.07K to 162.94K | |
| 27-Jul-22 6:20 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 25-Jul-22 | Grant | 43,550 | -- | -- | 34% 128.52K to 172.07K | |
| 27-Jul-22 6:19 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 25-Jul-22 | Grant | 60,300 | -- | -- | 34% 177.84K to 238.13K | |
| 27-Jul-22 6:18 PM View: | Kosacz Barbara COO & General Counsel | Kronos Bio, Inc. (KRON) | 25-Jul-22 | Grant | 53,600 | -- | -- | 7% 738.02K to 791.62K | |
| 27-Jul-22 6:22 PM View: | Al-Wakeel Yasir B. Chief Financial Officer | Kronos Bio, Inc. (KRON) | 25-Jul-22 | Grant | 53,600 | -- | -- | 33% 163.24K to 216.84K | |
| 29-Jun-22 4:14 PM View: | de Backer Marianne Director | Kronos Bio, Inc. (KRON) | 22-Jun-22 | Grant | 11,333 | -- | -- | 412% 2.75K to 14.08K | |
| 29-Jun-22 4:15 PM View: | Yang Taiyin Director | Kronos Bio, Inc. (KRON) | 22-Jun-22 | Grant | 11,333 | -- | -- | 100% 0 to 11.33K | |
| 19-May-22 6:03 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 19-May-22 | Purchase | 300,000 | $3.78 | $1,134,510.00 | 5% 5.94M to 6.24M | |
| 19-May-22 6:03 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 18-May-22 | Purchase | 206,198 | $3.72 | $768,046.00 | 4% 5.73M to 5.94M | |
| 19-May-22 6:03 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 17-May-22 | Private Purchase | 90,931 | $3.83 | $348,529.00 | 2% 5.64M to 5.73M | |
| 09-Mar-22 4:40 PM View: | Kazam Joshoa A Director | Kronos Bio, Inc. (KRON) | 07-Mar-22 | Gift | 211,000 | -- | -- | 223% 94.48K to 305.48K | |
| 09-Mar-22 4:40 PM View: | Kazam Joshoa A Director | Kronos Bio, Inc. (KRON) | 07-Mar-22 | Gift | 211,000 | -- | -- | (69%) 305.48K to 94.48K | |
| 17-Feb-22 5:21 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 15-Feb-22 | Grant | 43,550 | -- | -- | 51% 84.97K to 128.52K | |
| 17-Feb-22 5:19 PM View: | Al-Wakeel Yasir B. Chief Financial Officer | Kronos Bio, Inc. (KRON) | 15-Feb-22 | Grant | 53,600 | -- | -- | 49% 109.64K to 163.24K | |
| 17-Feb-22 5:22 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 15-Feb-22 | Grant | 60,300 | -- | -- | 51% 117.53K to 177.84K | |
| 17-Feb-22 5:23 PM View: | Kosacz Barbara COO & General Counsel | Kronos Bio, Inc. (KRON) | 15-Feb-22 | Grant | 53,600 | -- | -- | 8% 684.42K to 738.02K | |
| 15-Dec-21 5:08 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 13-Dec-21 | Market Sale | 11,386 | $12.37 | $140,845.00 | (12%) 96.36K to 84.97K | (6%) |
| 15-Dec-21 5:06 PM View: | Dimartino Jorge Chief Medical Officer & VP | Kronos Bio, Inc. (KRON) | 13-Dec-21 | Market Sale | 16,402 | $12.37 | $202,893.00 | (12%) 133.94K to 117.53K | (6%) |
| 08-Dec-21 6:21 PM View: | Bischofberger Norbert W President & CEO Director | Kronos Bio, Inc. (KRON) | 06-Dec-21 | Market Purchase | 14,356 | $12.09 | $173,492.00 | < 1% 5.62M to 5.64M | 8% |
| 02-Dec-21 5:12 PM View: | de Backer Marianne Director | Kronos Bio, Inc. (KRON) | 01-Dec-21 | Market Purchase | 1,150 | $11.57 | $13,305.50 | 72% 1.6K to 2.75K | (2%) |
| 04-Oct-21 6:24 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 04-Oct-21 | Option Exercise | 9,189 | $3.27 | $30,048.00 | 10% 96.36K to 105.55K | |
| 04-Oct-21 6:24 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 04-Oct-21 | Market Option Sale (Planned) | 9,189 | $20.81 | $191,195.00 | (9%) 105.55K to 96.36K | |
| 09-Sep-21 1:23 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 07-Sep-21 | Market Option Sale (Planned) | 9,189 | $21.91 | $201,302.00 | (9%) 105.55K to 96.36K | |
| 09-Sep-21 1:23 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 07-Sep-21 | Option Exercise | 9,189 | $3.27 | $30,048.00 | 10% 96.36K to 105.55K | |
| 24-Aug-21 7:24 PM View: | de Backer Marianne Director | Kronos Bio, Inc. (KRON) | 20-Aug-21 | Market Purchase | 1,000 | $19.57 | $19,565.00 | 167% 0.6K to 1.6K | 4% |
| 03-Aug-21 5:13 PM View: | Dinsmore Christopher Chief Scientific Officer | Kronos Bio, Inc. (KRON) | 02-Aug-21 | Option Exercise | 9,189 | $3.27 | $30,048.00 | 10% 96.36K to 105.55K |
